A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C–Associated Liver Cirrhosis-Reference-Cited by-同舟云学术

A Risk for Hepatocellular Carcinoma Persists Long-term After Sustained Virologic Response in Patients With Hepatitis C–Associated Liver Cirrhosis

Published:2013-04-24 Issue:2 Volume:57 Page:230-236
ISSN:1537-6591
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Aleman Soo,Rahbin Nogol,Weiland Ola,Davidsdottir Loa,Hedenstierna Magnus,Rose Nina,Verbaan Hans,Stål Per,Carlsson Tony,Norrgren Hans,Ekbom Anders,Granath Fredrik,Hultcrantz Rolf

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/57/2/230/17854204/cit234.pdf

Reference24 articles.

1. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C–related advanced liver disease;Lok;Gastroenterology,2009

2. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma;J Hepatol,2012

3. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection;Fried;N Engl J Med,2002

4. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose;Hadziyannis;Ann Intern Med,2004

5. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial;Manns;Lancet,2001

Cited by 207 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lasting differential gene expression of circulating CD8 T cells in chronic HCV infection with cirrhosis identifies a role for Hedgehog signaling in cellular hyperfunction;Frontiers in Immunology;2024-06-03

2. Can Nutraceuticals Support the Treatment of MASLD/MASH, and thus Affect the Process of Liver Fibrosis?;International Journal of Molecular Sciences;2024-05-11

3. Evaluation of patients treated with direct-acting anti-viral therapy for chronic hepatitis C and their risk of hepatocellular carcinoma in Hong Kong;BMC Gastroenterology;2024-01-25

4. Noninvasive assessment of liver fibrosis can predict clinical outcomes at late follow-up after a sustained virological response in HCV patients?;Clinics;2024-01

5. Are We Aware of Hepatitis C Infection? HCV Results from the Tertiary Reference Center in the Aegean Region from Turkey;International Journal of Clinical Practice;2024-01